United Kingdom · Funded startup
Funding summaryUpdated 26 Oct 2026
$143Mraised across 4 rounds since 2016, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Source recorded
Reported by FinSMEs
Achilles Therapeutics filed 3 raises, $1.4M in all. Filings say how much was sold and to how many investors; they never name the investors.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
RA Capital ManagementL
Perceptive Advisors
Forbion Capital Partners
Redmile Group
OrbiMed
Invus
UCL Technology Fund
SynconaCRTMissing a round, or an investor who was in one? Tell us.
Achilles Therapeutics's investors include RA Capital Management, Perceptive Advisors, Forbion Capital Partners, Redmile Group and OrbiMed, and 4 more on record.
Achilles Therapeutics has raised $143M across 4 rounds since 2016.
Achilles Therapeutics's most recent round, $1.4M, was in Feb 2025.
Achilles Therapeutics's largest round on record is $121M (Series B), in Sept 2019, led by RA Capital Management.
Achilles Therapeutics's first round on record, in Nov 2016, was backed by UCL Technology Fund, Syncona and CRT.
Achilles Therapeutics's latest named round is a Grant, in Jul 2022.
Achilles Therapeutics is based in the United Kingdom.
RA Capital Management led the Series B in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
